Corient Private Wealth LLC Decreases Holdings in Mettler-Toledo International, Inc. $MTD

Corient Private Wealth LLC trimmed its holdings in Mettler-Toledo International, Inc. (NYSE:MTDFree Report) by 33.1% in the fourth quarter, HoldingsChannel reports. The fund owned 43,082 shares of the medical instruments supplier’s stock after selling 21,330 shares during the period. Corient Private Wealth LLC’s holdings in Mettler-Toledo International were worth $60,810,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in MTD. Capital International Investors lifted its stake in shares of Mettler-Toledo International by 12.7% in the 4th quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock valued at $1,351,064,000 after acquiring an additional 109,508 shares during the last quarter. Alliancebernstein L.P. raised its holdings in shares of Mettler-Toledo International by 10.7% during the third quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock valued at $974,633,000 after acquiring an additional 76,478 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its holdings in shares of Mettler-Toledo International by 0.5% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock valued at $964,174,000 after acquiring an additional 3,157 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Mettler-Toledo International by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock valued at $830,879,000 after purchasing an additional 14,106 shares in the last quarter. Finally, Norges Bank purchased a new stake in Mettler-Toledo International in the fourth quarter worth about $520,989,000. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,145.08 on Friday. The company has a market capitalization of $23.14 billion, a price-to-earnings ratio of 26.85, a price-to-earnings-growth ratio of 2.39 and a beta of 1.27. The company’s 50-day moving average is $1,190.78 and its 200 day moving average is $1,301.85. Mettler-Toledo International, Inc. has a one year low of $1,023.05 and a one year high of $1,525.17.

Mettler-Toledo International (NYSE:MTDGet Free Report) last released its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $8.70 by $0.21. The business had revenue of $947.13 million for the quarter, compared to analysts’ expectations of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The firm’s quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the firm posted $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, research analysts predict that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have weighed in on MTD shares. Citigroup cut their price objective on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. JPMorgan Chase & Co. lowered their target price on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a research note on Monday, May 11th. Stifel Nicolaus decreased their price target on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating for the company in a research note on Monday, May 18th. Wall Street Zen downgraded shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Robert W. Baird lowered their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Six investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $1,408.55.

Read Our Latest Stock Report on Mettler-Toledo International

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Featured Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.